Here's the live share price of Nectar Lifesciences along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Nectar Lifesciences | 4.05 | 7.71 | -4.67 | -19.22 | -43.07 | -8.88 | -16.11 |
| Sun Pharmaceutical Industries | -0.24 | 11.74 | 8.70 | 6.34 | 8.56 | 24.54 | 21.31 |
| Divi's Laboratories | -1.02 | 9.31 | 7.59 | 0.73 | 9.34 | 26.00 | 10.32 |
| Torrent Pharmaceuticals | 0.52 | 4.81 | 7.51 | 14.50 | 35.51 | 38.45 | 26.30 |
| Dr. Reddy's Laboratories | -3.08 | 2.83 | 0.20 | 2.88 | 5.25 | 12.45 | 3.67 |
| Cipla | -5.13 | 6.92 | -2.68 | -15.12 | -14.76 | 11.48 | 7.58 |
| Lupin | -8.26 | -3.10 | 1.89 | 9.15 | 8.61 | 42.54 | 13.10 |
| Mankind Pharma | 0.66 | 14.34 | 15.39 | 5.38 | -6.69 | 19.43 | 10.79 |
| Zydus Lifesciences | -0.76 | 0.96 | 3.00 | -1.29 | 3.37 | 21.99 | 7.57 |
| Aurobindo Pharma | 0.35 | 11.12 | 29.62 | 23.15 | 21.78 | 34.63 | 7.93 |
| Laurus Labs | 8.08 | 16.88 | 25.88 | 27.54 | 113.52 | 59.97 | 21.30 |
| Alkem Laboratories | -0.62 | 2.72 | 1.92 | -3.79 | 7.44 | 17.31 | 12.95 |
| Biocon | 5.62 | 16.58 | 6.45 | -3.57 | 21.99 | 17.95 | 0.85 |
| Glenmark Pharmaceuticals | -4.98 | 2.80 | 12.97 | 20.21 | 59.22 | 54.41 | 29.31 |
| Abbott India | 2.31 | 4.58 | 1.64 | -8.97 | -11.57 | 8.25 | 10.79 |
| Anthem Biosciences | 4.15 | 9.67 | 16.19 | 14.62 | 9.58 | 3.10 | 1.85 |
| GlaxoSmithKline Pharmaceuticals | 0.55 | 1.16 | -6.02 | -2.24 | -12.63 | 24.08 | 10.50 |
| Ajanta Pharma | 0.15 | 6.98 | 6.13 | 21.60 | 19.53 | 34.88 | 18.33 |
| Ipca Laboratories | -3.91 | 3.57 | 0.94 | 15.35 | 6.99 | 29.33 | 7.06 |
| J B Chemicals & Pharmaceuticals | -0.48 | 6.59 | 12.55 | 17.10 | 34.84 | 27.74 | 25.17 |
Over the last one year, Nectar Lifesciences has declined 43.07% compared to peers like Sun Pharmaceutical Industries (8.56%), Divi's Laboratories (9.34%), Torrent Pharmaceuticals (35.51%). From a 5 year perspective, Nectar Lifesciences has underperformed peers relative to Sun Pharmaceutical Industries (21.31%) and Divi's Laboratories (10.32%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 13.22 | 13.21 |
| 10 | 12.82 | 12.95 |
| 20 | 12.5 | 12.52 |
| 50 | 11.64 | 12.42 |
| 100 | 14.15 | 13.4 |
| 200 | 14.79 | 15.83 |
In the latest quarter, Nectar Lifesciences remained same as its previous close in promoter holding, while DII stake increased to 4.02%, FII holding rose to 0.60%, and public shareholding moved down to 43.52% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Apr 28, 2026, 09:59 PM IST IST | Nectar Lifesciences - Update On Slump Sale |
| Apr 28, 2026, 06:51 PM IST IST | Nectar Lifesciences - Disclosure As Per Regulation 30 Of The Securities And Exchange Of Board Of India (Listing Obligations A |
| Apr 08, 2026, 06:50 PM IST IST | Nectar Lifesciences - Second 100 Days 'Saksham Niveshak' Campaign- Shareholder Outreach Initiative. |
| Apr 07, 2026, 02:00 AM IST IST | Nectar Lifesciences - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Mar 24, 2026, 07:05 PM IST IST | Nectar Lifesciences - Disclosure As Per Regulation 30 Of The Securities And Exchange Of Board Of India (Listing Obligations A |
Nectar Lifesciences Ltd. is a Public Limited Listed company incorporated on 27/06/1995 and has its registered office in the State of Punjab, India. Company's Corporate Identification Number(CIN) is L24232PB1995PLC016664 and registration number is 016664. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 1669.97 Cr. and Equity Capital is Rs. 22.43 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Nectar Lifesciences is ₹12.86 as on May 12, 2026.
The Nectar Lifesciences is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Nectar Lifesciences is ₹288.40 Cr as on May 12, 2026.
Today’s highest and lowest price of Nectar Lifesciences are ₹13.49 and ₹12.82.
The 52-week high/low is the highest and lowest price at which Nectar Lifesciences stock has traded in the past 52-week or nearly a year. The 52-week high of Nectar Lifesciences is ₹28.27 and 52-week low of Nectar Lifesciences is ₹9.20 as on May 12, 2026.
The Nectar Lifesciences has shown returns of -4.6% over the past day, 7.71% for the past month, -3.6% over 3 months, -42.49% over 1 year, -8.88% across 3 years, and -16.11% over 5 years.
P/E ratio of and PB ratio of Nectar Lifesciences are -0.81 and 0.39 on May 12, 2026. While the company gives a dividend yield of 0.00 per annum.